Arterioportal shunts in cirrhotic patients: Evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide
K. Mori et al., Arterioportal shunts in cirrhotic patients: Evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide, AM J ROENTG, 175(6), 2000, pp. 1659-1664
Citations number
21
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
OBJECTIVE. The study objective was to distinguish between the features of t
umorous and nontumorous arterioportal shunts on superparamagnetic iron oxid
e-enhanced MR imaging in patients with cirrhosis.
SUBJECTS AND METHODS. Ten arterioportal shunts in eight patients, including
four tumorous and six nontumorous arterioportal shunts, were evaluated on
T2-weighted turbo spin-echo and T2*-weighted gradient-echo sequences before
and after administration of superparamagnetic iron oxide. Qualitatively, t
he relative signal intensity of the: arterioportal shunt compared with that
of the surrounding liver parenchyma was categorized into three grades: hig
h, slightly high, and not detected. Quantitatively, signal-to-noise ratio,
contrast-to-noise ratio, lesion-to-liver contrast, and percentage enhanceme
nt were calculated and compared between tumorous and nontumorous arteriopor
tal shunts by a nonparametric statistical test (Mann-Whitney test).
RESULTS. Qualitatively, all four tumorous arterioportal shunts appeared as
areas of slightly high or high intensity without and with superparamagnetic
iron oxide on T2-weighted turbo spin-echo images and changed from isointen
sity to high intensity after the administration of superparamagnetic iron o
xide on T2*-weighted gradient-echo images. All non-tumorous arterioportal s
hunts except one could not he recognized without or with superparamagnetic
iron oxide on either sequence. Quantitatively, with superparamagnetic iron
oxide the contrast-to-noise ratio and the lesion-to-liver contrast of the t
umorous asterioportal shunts were significantly higher than those of the no
ntumorous arterioportal shunts.
CONCLUSION. Tumorous arterioportal shunts are seen as areas of reduced sign
al loss, whereas most nontumorous arterioportal shunts are seen as areas of
normal signal loss, like the normal liver parenchyma. The difference is mo
re marked on T2*-weighted gradient-echo images than on T2-weighted turbo sp
in-echo images.